T1	Participants 322 504	OA patients to etoricoxib 90 mg, then to 60 mg once daily vs diclofenac 75 mg twice daily; RA patients were randomized to etoricoxib 90 mg once daily or diclofenac 75 mg twice daily.
T2	Participants 775 835	23 504 patients were randomized with mean treatment duration
T3	Participants 709 717	patients
T4	Participants 1169 1183	patient cohort
T5	Participants 1290 1300	RA cohorts
T6	Participants 1521 1532	Both agents
